| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.4M | -10.5% |
| SG&A Expense | $6.1M | -42.7% |
| Operating Income | -$15.5M | +26.7% |
| Income Tax | $0 | -100.0% |
| Net Income | -$16.2M | +23.1% |
| EPS (Basic) | -$17.40 | -225.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.8M | +388.9% |
| Current Assets | $8.4M | +302.3% |
| Total Assets | $10.2M | +146.3% |
| Current Liabilities | $2.2M | -13.2% |
| Total Liabilities | $2.2M | -12.3% |
| Stockholders' Equity | $8.0M | +391.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.3M | +10.7% |
| Investing Cash Flow | $0 | -100.0% |
| Financing Cash Flow | $21.5M | +79.3% |